Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Palbociclib Treatment Patterns in Swedish Patients With Metastatic Breast Cancer - Swedish Ibrance Registries Insights (SIRI)

NCT04654208 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT04654208
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04654208 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Palbociclib Treatment Patterns in Swedish Patients With Metastatic Breast Cancer - Swedish Ibrance Registries Insights (SIRI)
Lead sponsor
Pfizer
Phase
Observational
Overall status
Recruiting
Start date
December 15, 2020
Completion date
May 31, 2026
Enrollment
1,500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malignant neoplasm of breast